Clinical trial · Observational
Prognostic Evaluation Prediction Model Survival Spinal Epidural Metastases
Prognostic Evaluation of Prediction Model Survival Spinal Epidural Metastases
NCT06411015CI-TRIAL-00077072completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients with symptomatic spinal metatstasis will be prosepectively included in a database after theu signes informed consent. Minimally six months after inclusion the survival status is analyzed. These are correlated with factors that are used in an earlier develloped prediction model
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Predictive Cancer Model | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- survival after diagnosis of spinal metastasis
- timeFrame
- minimal 6 months after inclusion
- description
- survival after diagnosis of spinal metastasis
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients with spinal spinal metastasis * symptomatic * adult * informed consent Exclusion Criteria: * not understanding informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.